Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Jerald Gong and Pierluigi Porcu.
Connection Strength

0.751
  1. Barta SK, Gong J, Porcu P. Brentuximab vedotin in the treatment of CD30-positive PTCL. Blood. 2019 Oct 25.
    View in: PubMed
    Score: 0.217
  2. Sokol K, Kartan S, Johnson WT, Alpdogan O, Nikbakht N, Haverkos BM, Gong J, Porcu P. Extreme Peripheral Blood Plasmacytosis Mimicking Plasma Cell Leukemia as a Presenting Feature of Angioimmunoblastic T-Cell Lymphoma (AITL). Front Oncol. 2019; 9:509.
    View in: PubMed
    Score: 0.212
  3. Oluwasanjo A, Kartan S, Johnson W, Alpdogan O, Gru A, Mishra A, Haverkos BM, Gong J, Porcu P. Peripheral T-Cell Lymphoma, not Otherwise Specified (PTCL-NOS). Cancer Treat Res. 2019; 176:83-98.
    View in: PubMed
    Score: 0.206
  4. Pan J, Ghimire S, Alpdogan SO, Chapman A, Carabasi M, DiMeglio M, Gong J, Martinez-Outschoorn U, Rose L, Ramirez M, Wagner JL, Weiss M, Flomenberg N, Pro B, Porcu P, Filicko-OHara J, Gaballa S. Phase I/II study of bendamustine in combination with ofatumumab, carboplatin, etoposide (BOCE) for relapsed or refractory aggressive B-cell non-Hodgkin lymphoma. Leuk Lymphoma. 2020 Nov 04; 1-8.
    View in: PubMed
    Score: 0.058
  5. Hannon M, Porcu P, Gong JZ, Ackermann L. Relapsed Splenic Lymphoma Mimicking Recurrent Pyelonephritis. Am J Med. 2020 Sep 28.
    View in: PubMed
    Score: 0.058
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.